Clinical Trials Directory

Trials / Completed

CompletedNCT01241006

Single Oral Dose of Dexamethasone Versus Five Days of Prednisone in Adult Asthma

A Randomized Double-Blind Controlled Trial of Single Oral Dose Dexamethasone Versus Five Days of Oral Prednisone in Acute Mild to Moderate Adult Asthma

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
376 (actual)
Sponsor
Alameda County Medical Center · Academic / Other
Sex
All
Age
18 Years – 55 Years
Healthy volunteers
Not accepted

Summary

This study seeks to compare the effectiveness of a single dose of oral dexamethasone versus 5 days of oral prednisone in the treatment of mild to moderate asthma exacerbations to prevent relapse with an unscheduled return visit to a health care provider for additional asthma treatment within 14 days. The investigators hypothesize that the two treatments will be equally effective in relapse prevention.

Detailed description

Dexamethasone and Prednisone are both systemic corticosteroids. The study will compare a single dose of oral dexamethasone to 5 days of oral prednisone in the treatment of asthma. Oral corticosteroids are commonly prescribed following an asthma exacerbation as it has been demonstrated that these medications prevent relapse. Oral prednisone is the most common corticosteroid prescribed for asthma relapse prevention. The half life is around 4 hours and is typically prescribed for minimally 5 days. The study is evaluating the efficacy of a single dose of dexmethasone. The drug's efficicacy has been shown to be longer acting and up to 72 hours. A single dose would eliminate the need for a prescription for a drug like prednisone to hopefully improve compliance.

Conditions

Interventions

TypeNameDescription
DRUGDexamethasoneDexamethasone 12mg PO single dose x 1 Placebo 1 capsule PO for 4 days
DRUGPrednisonePrednisone 60mg PO q day for 5 days

Timeline

Start date
2011-01-01
Primary completion
2015-05-01
Completion
2015-05-01
First posted
2010-11-16
Last updated
2016-01-07

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01241006. Inclusion in this directory is not an endorsement.